SYRS vs GILD: Which Stock is Better?
Side-by-side comparison of Syros Pharmaceuticals Inc and Gilead Sciences Inc in 2026
SYRS
Syros Pharmaceuticals Inc
—
GILD
Gilead Sciences Inc
$131.27
Key Metrics Comparison
| Metric | SYRS | GILD | Winner |
|---|---|---|---|
| Market Cap | $0.01M | $160.15B | GILD |
| P/E Ratio | N/A | 17.55 | GILD |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze SYRS
Full quant analysis
Analyze GILD
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is SYRS or GILD a better investment?
Comparing SYRS and GILD: Syros Pharmaceuticals Inc has a market cap of $0.01M while Gilead Sciences Inc has $160.15B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between SYRS and GILD?
SYRS (Syros Pharmaceuticals Inc) and GILD (Gilead Sciences Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: SYRS or GILD?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: SYRS or GILD?
Both SYRS and GILD show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: SYRS or GILD?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: SYRS or GILD?
Gilead Sciences Inc (GILD) is larger with a market cap of $160.15B compared to $0.01M for SYRS.
Should I buy SYRS or GILD in 2026?
Both SYRS and GILD have investment merit. SYRS trades at $N/A while GILD trades at $131.27. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between SYRS and GILD stock?
Key differences: Market Cap ($0.01M vs $160.15B), P/E Ratio (N/A vs 17.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy SYRS or GILD in 2026?
The choice between SYRS and GILD depends on your investment goals. GILD shows higher revenue growth (0.0%). GILD has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between SYRS and GILD?
SYRS (Syros Pharmaceuticals Inc) has a market cap of $0.01M, while GILD (Gilead Sciences Inc) has a market cap of $160.15B. GILD is the larger company by market value.